Page 204 - Basic _ Clinical Pharmacology ( PDFDrive )
P. 204

190     SECTION III  Cardiovascular-Renal Drugs


                 Hypertension & Polypharmacy). Thiazide diuretics, ACE inhibi-  blood pressure telemonitoring with pharmacist case management,
                 tors, angiotensin receptor blockers, and calcium channel blockers   which has been shown to improve blood pressure control.
                 have all been shown to reduce complications of hypertension   In addition to noncompliance with medication, causes of fail-
                 and may be used for initial drug therapy. There has been con-  ure to respond to drug therapy include excessive sodium intake
                 cern that diuretics, by adversely affecting the serum lipid profile   and inadequate diuretic therapy with excessive blood volume,
                 or impairing glucose tolerance, may add to the risk of coronary   and  drugs  such  as  tricyclic  antidepressants,  nonsteroidal  anti-
                 disease, thereby offsetting the benefit of blood pressure reduc-  inflammatory drugs, over-the-counter sympathomimetics, abuse
                 tion. However, a large clinical trial comparing different classes   of  stimulants (amphetamine  or  cocaine), or excessive doses of
                 of antihypertensive mediations for initial therapy found that   caffeine and oral contraceptives that can interfere with actions of
                 chlorthalidone (a thiazide diuretic) was as effective as other agents   some antihypertensive drugs or directly raise blood pressure.
                 in reducing coronary heart disease death and nonfatal myocardial
                 infarction, and was superior to amlodipine in preventing heart   MANAGEMENT OF HYPERTENSIVE
                 failure and superior to lisinopril in preventing stroke. Beta block-  EMERGENCIES
                 ers are less effective in reducing cardiovascular events and are cur-
                 rently not recommended as first-line treatment for uncomplicated   Despite the large number of patients with chronic hypertension,
                 hypertension.                                       hypertensive  emergencies  are  relatively  rare.  Marked  or  sudden
                   The presence of concomitant disease should influence selection   elevation of blood pressure may be a serious threat to life, how-
                 of antihypertensive drugs because two diseases may benefit from a   ever, and prompt control of blood pressure is indicated. Most
                 single drug. For example, drugs that inhibit the renin-angiotensin   frequently, hypertensive emergencies occur in patients whose
                 system are particularly useful in patients with diabetes or evi-  hypertension is severe and poorly controlled and in those who
                 dence of chronic kidney disease with proteinuria. Beta blockers   suddenly discontinue antihypertensive medications.
                 or calcium channel blockers are useful in patients who also have
                 angina; diuretics, ACE inhibitors, angiotensin receptor blockers,   Clinical Presentation & Pathophysiology
                 β blockers, or hydralazine combined with nitrates in patients who
                 also have heart failure; and α  blockers in men who have benign   Hypertensive emergencies include hypertension associated with
                                       1
                 prostatic hyperplasia. Race may also affect drug selection: African   vascular damage (termed malignant hypertension) and hyperten-
                 Americans respond better on average to diuretics and calcium   sion  associated  with  hemodynamic  complications  such  as  heart
                 channel blockers than to β blockers and ACE inhibitors. Chinese   failure,  stroke,  or  dissecting  aortic  aneurysm.  The  underlying
                 patients are more sensitive to the effects of β blockers and may   pathologic process in malignant hypertension is a progressive
                 require lower doses.                                arteriopathy with inflammation and necrosis of arterioles. Vascular
                   If a single drug does not adequately control blood pressure,   lesions occur in the kidney, which releases renin, which in turn
                 drugs with different sites of action can be combined to effectively   stimulates production of angiotensin and aldosterone, which
                 lower blood pressure while minimizing toxicity (“stepped care”). If   further increase blood pressure.
                 three drugs are required, combining a diuretic, an ACE inhibitor   Hypertensive encephalopathy is a classic feature of malignant
                 or angiotensin receptor blocker, and a calcium channel blocker is   hypertension. Its clinical presentation consists of severe headache,
                 often effective. If a fourth drug is needed, a sympathoplegic agent   mental confusion, and apprehension. Blurred vision, nausea and
                 such as a  β blocker or clonidine should be considered. In the   vomiting, and focal neurologic deficits are common. If untreated,
                 USA, fixed-dose drug combinations containing a β blocker, plus   the syndrome may progress over a period of 12–48 hours to
                 an ACE inhibitor or angiotensin receptor blocker, plus a thiazide;   convulsions, stupor, coma, and even death.
                 and a calcium channel blocker plus an ACE inhibitor are available.
                 Fixed-dose combinations have the drawback of not allowing for   Treatment of Hypertensive Emergencies
                 titration of individual drug doses but have the advantage of allow-  The general management of hypertensive emergencies requires
                 ing fewer pills to be taken, potentially enhancing compliance.  monitoring the patient in an intensive care unit with continuous
                   Assessment of blood pressure during office visits should   recording of arterial blood pressure. Fluid intake and output must
                 include  measurement  of  recumbent,  sitting,  and  standing  pres-  be monitored carefully and  body weight measured daily as  an
                 sures. An attempt should be made to normalize blood pressure   indicator of total body fluid volume during the course of therapy.
                 in the posture or activity level that is customary for the patient.   Parenteral antihypertensive medications are used to lower
                 Although there  is still  some  debate about how  much blood   blood pressure rapidly (within a few hours); as soon as reasonable
                 pressure should be lowered, the recent Systolic Blood Pressure   blood pressure control is achieved, oral antihypertensive therapy
                 Intervention Trial (SPRINT) and several meta-analyses suggest a   should be substituted because this allows smoother long-term
                 target systolic blood pressure of 120 mm Hg for patients at high   management of hypertension. The goal of treatment in the first
                 cardiovascular risk. Systolic hypertension (> 150 mm Hg in the   few hours or days is not complete normalization of blood pressure
                 presence of normal diastolic blood pressure) is a strong cardiovas-  because chronic hypertension is associated with autoregula-
                 cular risk factor in people older than 60 years of age and should   tory changes in cerebral blood flow. Thus, rapid normaliza-
                 be treated. Recent advances in outpatient treatment include home   tion  of  blood  pressure  may  lead  to  cerebral hypoperfusion
   199   200   201   202   203   204   205   206   207   208   209